Patent · US Active

Compounds for treatment of cystic fibrosis

US9656972B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2014
Grant dateMay 23, 2017
Priority date
Expiry dateJul 2, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.